World's Best Scientists 2026 revealed!
Tetsuo Shiohara

Tetsuo Shiohara

D-Index & Metrics

Immunology

D-Index
64
Citations
16119
World Ranking
2920
National Ranking
122

Tetsuo Shiohara publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tetsuo Shiohara sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 318 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tetsuo Shiohara D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tetsuo Shiohara sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tetsuo Shiohara is affiliated with Kyorin University in Japan and has a research focus primarily within the field of Medicine. Their work spans several subfields, including Pharmacology, Rheumatology, Dermatology, Immunology, and Immunology and Allergy.

The main topics covered by their research include:

  • Drug-Induced Adverse Reactions
  • Urticaria and Related Conditions
  • Dermatology and Skin Diseases
  • Eosinophilic Disorders and Syndromes
  • Contact Dermatitis and Allergies
  • Allergic Rhinitis and Sensitization
  • Immune Cell Function and Interaction

Tetsuo Shiohara has published in multiple peer-reviewed venues. The most frequent publication venues are:

  • Journal of Investigative Dermatology
  • Journal of the European Academy of Dermatology and Venereology
  • The Journal of Dermatology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Journal of Dermatological Science

Among the recent papers associated with their work are:

  • Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus (2021), British Journal of Dermatology
  • Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms (2023), JAMA Dermatology
  • Association of HLA-A*11:01 with Sulfonamide-Related Severe Cutaneous Adverse Reactions in Japanese Patients (2020), Journal of Investigative Dermatology
  • 2020 guidelines for the diagnosis and treatment of prurigo (2021), The Journal of Dermatology
  • 2020 guidelines for the diagnosis and treatment of cutaneous pruritus (2021), The Journal of Dermatology

Frequent co-authors collaborating with Tetsuo Shiohara include:

  • Yoshiko Mizukawa
  • Yumi Aoyama
  • Natsumi Hama
  • Eishin Morita
  • Riichiro Abe

Best Publications

  • International Consensus on drug allergy.

    P. Demoly;N. F. Adkinson;K. Brockow;M. Castells

  • Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

    Takeshi Ozeki;Taisei Mushiroda;Amara Yowang;Atsushi Takahashi

  • Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses.

    Tetsuo Shiohara;Miyuki Inaoka;Yoko Kano

  • Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells

    Hiroyuki Tezuka;Yukiko Abe;Makoto Iwata;Hajime Takeuchi

  • Human Herpesvirus 6 Infection as a Risk Factor for the Development of Severe Drug-Induced Hypersensitivity Syndrome

    Yosuke Suzuki;Reiko Inagi;Toshiya Aono;Koichi Yamanishi

  • Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile.

    H Kitagaki;N Ono;K Hayakawa;T Kitazawa

  • Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption

    Y. Kano;K. Hirahara;Y. Mitsuyama;R. Takahashi

  • Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome.

    Ryo Takahashi;Yoko Kano;Yoshimi Yamazaki;Momoko Kimishima

  • Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia.

    Yoko Kano;Miyuki Inaoka;Tetsuo Shiohara

  • Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease.

    Y. Kano;K. Hiraharas;K. Sakuma;T. Shiohara

  • Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.

    Tetsuo Shiohara;Yoshiko Mizukawa

  • Fixed drug eruption: pathogenesis and diagnostic tests.

    Tetsuo Shiohara

  • A Complex Interaction Between Drug Allergy and Viral Infection

    Tetsuo Shiohara;Yoko Kano

  • The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.

    Yoko Kano;Tetsuo Shiohara

  • Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).

    Hidehisa Saeki;Hidemi Nakagawa;Ko Nakajo;Taeko Ishii

  • Animal models for atopic dermatitis: are they relevant to human disease?

    Tetsuo Shiohara;Jun Hayakawa;Yoshiko Mizukawa

  • Immediate-Type Hypersensitivity Response Followed by a Late Reaction Is Induced by Repeated Epicutaneous application of Contact Sensitizing Agents in Mice

    Unknown

  • A mouse model for vitiligo

    Aaron B. Lerner;Tetsuo Shiohara;Raymond E. Boissy;Kirsten A. Jacobson

  • Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome.

    Yoko Kano;Tadashi Ishida;Kazuhisa Hirahara;Tetsuo Shiohara

  • Direct evidence for interferon-γ production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption

    Yoshiko Mizukawa;Yoshimi Yamazaki;Yuichi Teraki;Jun Hayakawa

  • Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

    Chie Sotozono;Mayumi Ueta;Eiji Nakatani;Amane Kitami

Frequent Co-Authors

Andrew Yule Finlay
Andrew Yule Finlay Cardiff University
Lars E. French
Lars E. French Ludwig-Maximilians-Universität München
Hisashi Narimatsu
Hisashi Narimatsu National Institute of Advanced Industrial Science and Technology
Koji Hashimoto
Koji Hashimoto Ehime University
Hajime Iizuka
Hajime Iizuka Asahikawa Medical University
Akemi Ishida-Yamamoto
Akemi Ishida-Yamamoto Asahikawa Medical University
Keiji Iwatsuki
Keiji Iwatsuki Okayama University
Hideo Yagita
Hideo Yagita Juntendo University
Yoshizo Asano
Yoshizo Asano Fujita Health University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA opens doors to various advanced healthcare roles, especially within nursing and research fields. For those interested in clinical practice enhancements, programs like the fnp to acute care np bridge program offer specialized training to transition from Family Nurse Practitioner roles to acute care settings.

Students aiming for faster entry into nurse practitioner roles can benefit from reviewing top accelerated np programs online. These programs streamline the path to advanced practice, melding rigorous coursework with flexible delivery suited for working professionals.

For those beginning without a nursing background, accessible options such as online adn programs for non nurses are pivotal. They provide foundational nursing education tailored to learners new to the healthcare field, enabling a smoother transition into the immunology-related aspects of patient care.

Additionally, the easiest absn programs to get into present accessible routes for aspiring nurses to rapidly earn their Bachelor of Science in Nursing. This degree is essential for those looking to integrate immunological knowledge with primary healthcare delivery.

Best Scientists Citing Tetsuo Shiohara

Trending Scientists

Recently Published Articles